𝐂𝐨𝐦𝐩𝐮𝐭𝐞𝐫-𝐀𝐢𝐝𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐒𝐢𝐳𝐞, 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧, 𝐓𝐨𝐩 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟑𝟎
According to the Market Statsville Group (MSG), the Global Computer-aided Drug Discovery Market size was valued at USD 3,146.8 million in 2021 and is projected to reach USD 10,897.9 million by 2030, growing at a CAGR of 14.8% from 2022 to 2030. The demand for computer-aided drug discovery increased due to the high efficiency reached using computer-aided drug discovery growing prevalence of chronic disease across the globe coupled with increasing investment in drug discovery projects will drive the market's growth over the forecast period. High costs and cyberattacks may hamper the market's growth. However, advancing technologies creates lucrative opportunities for the market’s growth.
Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/computer-aided-drug-discovery-market?utm_source=free&utm_medium=harsh
Scope of the Global Computer-Aided Drug Discovery Market
On the basis of the study, the computer-aided drug discovery market is categorized into the following segments: type, therapeutic area, and end-user, at the regional and global levels.
By Type Outlook (Sales, USD Million, 2017-2030)
Structure-based drug design
Ligand-based drug design
Sequence-based approaches
By Therapeutic Area Outlook (Sales, USD Million, 2017-2030)
Neurology
Oncology
Cardiovascular disease
Respiratory disease
Diabetes
Others
By End-User Outlook (Sales, USD Million, 2017-2030)
Biotechnology companies
Pharmaceutical companies
Research laboratories
By Region Outlook (Sales, USD Million, 2017-2030)
North America
US
Canada
Mexico
Europe
Germany
Italy
France
UK
Spain
Poland
Russia
The Netherlands
Norway
Czech Republic
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Indonesia
Malaysia
Thailand
Singapore
Australia & New Zealand
Rest of Asia Pacific
South America
Brazil
Argentina
Colombia
Rest of South America
The Middle East & Africa
Saudi Arabia
UAE
South Africa
Northern Africa
Rest of MEA
Direct Purchase Report: https://www.marketstatsville.com/buy-now/computer-aided-drug-discovery-market?opt=3338&utm_source=free&utm_medium=harsh
Key Market Players in the Global Computer-Aided Drug Discovery Market
Computer-aided drug discovery market has highly competitive rivalry due to the presence of various well-established market players coupled with the growing investment in drug discovery by various market players and governments. Such factors drive the market's growth, which major market players seek as an advantage and gain profit margins. Some of the major players are as follows:
BOCSCI Inc.
Bioduro-Sundia
Schrödinger, Inc.
Aragen Life Sciences Pvt. Ltd.
Aris Pharmaceuticals, Inc
Charles River Laboratories
Bayer AG
AstraZeneca,
Albany Molecular Research Inc. (AMRI)
Others prominent players
According to the Market Statsville Group (MSG), the Global Computer-aided Drug Discovery Market size was valued at USD 3,146.8 million in 2021 and is projected to reach USD 10,897.9 million by 2030, growing at a CAGR of 14.8% from 2022 to 2030. The demand for computer-aided drug discovery increased due to the high efficiency reached using computer-aided drug discovery growing prevalence of chronic disease across the globe coupled with increasing investment in drug discovery projects will drive the market's growth over the forecast period. High costs and cyberattacks may hamper the market's growth. However, advancing technologies creates lucrative opportunities for the market’s growth.
Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/computer-aided-drug-discovery-market?utm_source=free&utm_medium=harsh
Scope of the Global Computer-Aided Drug Discovery Market
On the basis of the study, the computer-aided drug discovery market is categorized into the following segments: type, therapeutic area, and end-user, at the regional and global levels.
By Type Outlook (Sales, USD Million, 2017-2030)
Structure-based drug design
Ligand-based drug design
Sequence-based approaches
By Therapeutic Area Outlook (Sales, USD Million, 2017-2030)
Neurology
Oncology
Cardiovascular disease
Respiratory disease
Diabetes
Others
By End-User Outlook (Sales, USD Million, 2017-2030)
Biotechnology companies
Pharmaceutical companies
Research laboratories
By Region Outlook (Sales, USD Million, 2017-2030)
North America
US
Canada
Mexico
Europe
Germany
Italy
France
UK
Spain
Poland
Russia
The Netherlands
Norway
Czech Republic
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Indonesia
Malaysia
Thailand
Singapore
Australia & New Zealand
Rest of Asia Pacific
South America
Brazil
Argentina
Colombia
Rest of South America
The Middle East & Africa
Saudi Arabia
UAE
South Africa
Northern Africa
Rest of MEA
Direct Purchase Report: https://www.marketstatsville.com/buy-now/computer-aided-drug-discovery-market?opt=3338&utm_source=free&utm_medium=harsh
Key Market Players in the Global Computer-Aided Drug Discovery Market
Computer-aided drug discovery market has highly competitive rivalry due to the presence of various well-established market players coupled with the growing investment in drug discovery by various market players and governments. Such factors drive the market's growth, which major market players seek as an advantage and gain profit margins. Some of the major players are as follows:
BOCSCI Inc.
Bioduro-Sundia
Schrödinger, Inc.
Aragen Life Sciences Pvt. Ltd.
Aris Pharmaceuticals, Inc
Charles River Laboratories
Bayer AG
AstraZeneca,
Albany Molecular Research Inc. (AMRI)
Others prominent players
𝐂𝐨𝐦𝐩𝐮𝐭𝐞𝐫-𝐀𝐢𝐝𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐒𝐢𝐳𝐞, 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧, 𝐓𝐨𝐩 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟑𝟎
According to the Market Statsville Group (MSG), the Global Computer-aided Drug Discovery Market size was valued at USD 3,146.8 million in 2021 and is projected to reach USD 10,897.9 million by 2030, growing at a CAGR of 14.8% from 2022 to 2030. The demand for computer-aided drug discovery increased due to the high efficiency reached using computer-aided drug discovery growing prevalence of chronic disease across the globe coupled with increasing investment in drug discovery projects will drive the market's growth over the forecast period. High costs and cyberattacks may hamper the market's growth. However, advancing technologies creates lucrative opportunities for the market’s growth.
Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/computer-aided-drug-discovery-market?utm_source=free&utm_medium=harsh
Scope of the Global Computer-Aided Drug Discovery Market
On the basis of the study, the computer-aided drug discovery market is categorized into the following segments: type, therapeutic area, and end-user, at the regional and global levels.
By Type Outlook (Sales, USD Million, 2017-2030)
Structure-based drug design
Ligand-based drug design
Sequence-based approaches
By Therapeutic Area Outlook (Sales, USD Million, 2017-2030)
Neurology
Oncology
Cardiovascular disease
Respiratory disease
Diabetes
Others
By End-User Outlook (Sales, USD Million, 2017-2030)
Biotechnology companies
Pharmaceutical companies
Research laboratories
By Region Outlook (Sales, USD Million, 2017-2030)
North America
US
Canada
Mexico
Europe
Germany
Italy
France
UK
Spain
Poland
Russia
The Netherlands
Norway
Czech Republic
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Indonesia
Malaysia
Thailand
Singapore
Australia & New Zealand
Rest of Asia Pacific
South America
Brazil
Argentina
Colombia
Rest of South America
The Middle East & Africa
Saudi Arabia
UAE
South Africa
Northern Africa
Rest of MEA
Direct Purchase Report: https://www.marketstatsville.com/buy-now/computer-aided-drug-discovery-market?opt=3338&utm_source=free&utm_medium=harsh
Key Market Players in the Global Computer-Aided Drug Discovery Market
Computer-aided drug discovery market has highly competitive rivalry due to the presence of various well-established market players coupled with the growing investment in drug discovery by various market players and governments. Such factors drive the market's growth, which major market players seek as an advantage and gain profit margins. Some of the major players are as follows:
BOCSCI Inc.
Bioduro-Sundia
Schrödinger, Inc.
Aragen Life Sciences Pvt. Ltd.
Aris Pharmaceuticals, Inc
Charles River Laboratories
Bayer AG
AstraZeneca,
Albany Molecular Research Inc. (AMRI)
Others prominent players
0 Comments
0 Shares